Log In
Print this Print this

Biosimilar recombinant factor VIII (GNR-002)

  Manage Alerts
Collapse Summary General Information
Company International Biotech Center Generium (IBC Generium)
DescriptionB-domain deleted recombinant factor VIII (FVIII)
Molecular Target
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II/III
Standard IndicationHemophilia
Indication DetailsTreat hemophilia Type A
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today